HOME >> MEDICINE >> NEWS
Trial reveals safer and simpler approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET.

Aminoglycoside antibiotics are widely used for the management of patients who have cystic fibrosis and chronic chest infection with a bacterium called Pseudomonas aerginosa. Currently patients are given aminoglycosides three times daily. The drugs can cause damage to kidney function and hearing loss.

Alan Smyth (University of Nottingham, UK) and colleagues recruited 219 cystic fibrosis patients (125 children and 94 adults) between 1999 and 2003 in the UK. The patients were randomly assigned to receive an aminoglycoside called tobramycin intravenously once or three times daily for 14 days. The researchers measured changes in lung function and found that the two treatments had a similar effect. However in children, the once daily treatment caused fewer kidney related side effects.

Dr Alan Smyth comments: "Our results are likely to affect aminoglycoside prescription in cystic fibrosis in clinical practice. Once daily treatment may be preferred by patients receiving intravenous antibiotics because of its convenience. Antipseudomonal antibiotics are usually given as combinations of two or more drugs in cystic fibrosis because of concerns of emerging antibiotic resistance. Most other antipseudomonal antibiotics need to be given three times daily and so further development of other once daily antibiotics would be useful."

In an accompanying commentary Heather VandenBussche (Bronson Methodist Hospital, Michigan, USA) and Michael Klepser (Ferris State University College of Pharmacy, Michigan, USA) write that several unanswered questions persist about once daily aminoglycoside dosing in cystic fibrosis patients.

Dr VandenBussche concludes: " Smyth and colleagues' report provides some useful insights into
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Feb-2005


Page: 1 2

Related medicine news :

1. Trials launched to test treatment of cognitive dysfunction in schizophrenia
2. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
3. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
4. Trial results have dramatically reduced HRT use
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2018)... ... October 17, 2018 , ... The Jacobs & Cushman San Diego Food Bank’s ... at a meeting of its Board of Directors. , California Association of Food ... California. CAFB provides its member food banks with a range of support services, direct ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... Optimization Services for upstream, midstream and downstream operators today announces Total Train Comprehensive ... a packaged release of critical system components focused on improving cybersecurity defense around ...
(Date:10/16/2018)... , ... October 16, 2018 , ... ... the recipient of the Academy of Integrative Health and Medicine’s (AIHM) Visionary Award ... natural medicine. , Dr. Pizzorno was selected as AIHM’s recipient of the ...
(Date:10/16/2018)... CHURCH, Va. (PRWEB) , ... October 16, 2018 ... ... FDAnews**, Oct. 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th ... since last year’s Inspections Summit that it sometimes feels difficult to keep up. ...
(Date:10/16/2018)... AUSTIN, Texas (PRWEB) , ... October 16, 2018 , ... The months of training are ... or last, their bodies will probably feel like they were put through the wringer after ... and sports injuries team at Medicine in Motion on how to treat the body ...
Breaking Medicine News(10 mins):
(Date:10/17/2018)... ... 17, 2018 , ... WHAT: , Hosted by MarketsandMarkets ... niche markets, Artificial Intelligence in Healthcare Conference will bring together healthcare ... from leading experts who are developing and deploying the technology. The industry experts ...
(Date:10/16/2018)... ... October 16, 2018 , ... Citrus Valley Health Partners and Keck School ... inclusive forum on the health care ecosystem of the San Gabriel Valley. , ... evidence-based dialogues and actionable solutions aimed at transforming the way health care is provided ...
(Date:10/16/2018)... ... October 16, 2018 , ... Founders ... development and marketing of algae-based omega-3 products, Ben Kelly of Algarithm Ingredients and ... in Houston, Texas on October 15. The title of their presentation was “Making ...
Breaking Medicine Technology:
Cached News: